Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 102, Issue 8, Pages 932-936Publisher
WILEY
DOI: 10.1002/jso.21657
Keywords
colorectal cancer; liver metastases; chemotherapy
Ask authors/readers for more resources
Neoadjuvant chemotherapy is increasingly used to improve outcome in patients with colorectal liver metastases (CLM). In patients with unresectable CLM, recent clinical trials evaluate the ability of chemotherapy to increase the resectability rate. In patients with resectable CLM, the objective is to decrease the risk of recurrence after hepatectomy that still remains elevated despite the improvement of the surgical technique. A multidisciplinary approach of patients with CLM is desirable whatever the initial status of resectability. J. Surg. Oncol. 2010; 102: 932-936. (C) 2010 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available